Fresenius Se Co Stock Fundamentals

FSNUF Stock  USD 32.85  0.00  0.00%   
Fresenius SE Co fundamentals help investors to digest information that contributes to Fresenius' financial success or failures. It also enables traders to predict the movement of Fresenius Pink Sheet. The fundamental analysis module provides a way to measure Fresenius' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Fresenius SE Co Company Profit Margin Analysis

Fresenius' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Fresenius Profit Margin

    
  0.04 %  
Most of Fresenius' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius SE Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Fresenius SE Co has a Profit Margin of 0.0402%. This is 100.36% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The profit margin for all United States stocks is 103.17% lower than that of the firm.

Fresenius SE Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fresenius's current stock value. Our valuation model uses many indicators to compare Fresenius value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius competition to find correlations between indicators driving Fresenius's intrinsic value. More Info.
Fresenius SE Co is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers reporting about  0.37  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius SE Co is roughly  2.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fresenius' earnings, one of the primary drivers of an investment's value.

Fresenius Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresenius could also be used in its relative valuation, which is a method of valuing Fresenius by comparing valuation metrics of similar companies.
Fresenius is currently under evaluation in profit margin category among its peers.

Fresenius Fundamentals

About Fresenius Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Fresenius SE Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius SE Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Fresenius Pink Sheet

Fresenius financial ratios help investors to determine whether Fresenius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fresenius with respect to the benefits of owning Fresenius security.